All a fair point Lazarus and Ace, but as you say Ace, it's a very fine line to walk with what to say, with a big drop off either side for the unwary.
To play devils advocate - isn't it also inherently wise for an investor in an industry to learn what's needed to be learned in order to form their own independent judgements on what is and is not significant in that industry? I certainly wouldn't invest in cancer pharmaceutical research without first thoroughly learning the background for the sector as it would all go straight over my head and I'd have no clue what means what. I'd be victim to the first fast talking snake oil salesman out there - and who's fault would that be?
- Forums
- ASX - By Stock
- MRD
- Ann: Exploration Update
Ann: Exploration Update, page-29
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MRD (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.784M |
Open | High | Low | Value | Volume |
0.1¢ | 0.1¢ | 0.1¢ | $658 | 658.4K |
Featured News
MRD (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online